PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-05-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.754 |
_version_ | 1811241756154396672 |
---|---|
author | Songlin Mu Zhijuan Liang Yongmei Wang Wendi Chu Yi‐Li Chen Qi Wang Guifeng Wang Chunhe Wang |
author_facet | Songlin Mu Zhijuan Liang Yongmei Wang Wendi Chu Yi‐Li Chen Qi Wang Guifeng Wang Chunhe Wang |
author_sort | Songlin Mu |
collection | DOAJ |
first_indexed | 2024-04-12T13:40:55Z |
format | Article |
id | doaj.art-2c491c0ad96e42348e50acb6e5888efb |
institution | Directory Open Access Journal |
issn | 2001-1326 |
language | English |
last_indexed | 2024-04-12T13:40:55Z |
publishDate | 2022-05-01 |
publisher | Wiley |
record_format | Article |
series | Clinical and Translational Medicine |
spelling | doaj.art-2c491c0ad96e42348e50acb6e5888efb2022-12-22T03:30:50ZengWileyClinical and Translational Medicine2001-13262022-05-01125n/an/a10.1002/ctm2.754PD‐L1/TIGIT bispecific antibody showed survival advantage in animal modelSonglin Mu0Zhijuan Liang1Yongmei Wang2Wendi Chu3Yi‐Li Chen4Qi Wang5Guifeng Wang6Chunhe Wang7Biotherapeutics Discovery Research Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai ChinaBiotherapeutics Discovery Research Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai ChinaBiotherapeutics Discovery Research Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai ChinaBiotherapeutics Discovery Research Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai ChinaDartsbio Pharmaceuticals, Ltd. Zhongshan ChinaBiotherapeutics Discovery Research Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai ChinaBiotherapeutics Discovery Research Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai ChinaBiotherapeutics Discovery Research Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai Chinahttps://doi.org/10.1002/ctm2.754 |
spellingShingle | Songlin Mu Zhijuan Liang Yongmei Wang Wendi Chu Yi‐Li Chen Qi Wang Guifeng Wang Chunhe Wang PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model Clinical and Translational Medicine |
title | PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model |
title_full | PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model |
title_fullStr | PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model |
title_full_unstemmed | PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model |
title_short | PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model |
title_sort | pd l1 tigit bispecific antibody showed survival advantage in animal model |
url | https://doi.org/10.1002/ctm2.754 |
work_keys_str_mv | AT songlinmu pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel AT zhijuanliang pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel AT yongmeiwang pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel AT wendichu pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel AT yilichen pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel AT qiwang pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel AT guifengwang pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel AT chunhewang pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel |